Annual EBITDA
-$28.52 M
+$13.19 M+31.63%
30 June 2024
Summary:
Renalytix annual earnings before interest, taxes, depreciation & amortization is currently -$28.52 million, with the most recent change of +$13.19 million (+31.63%) on 30 June 2024. During the last 3 years, it has risen by +$5.17 million (+15.34%). RNLX annual EBITDA is now -178.39% below its all-time high of -$10.24 million, reached on 30 June 2020.RNLX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$3.37 M
+$2.10 M+38.39%
30 September 2024
Summary:
Renalytix quarterly earnings before interest, taxes, depreciation & amortization is currently -$3.37 million, with the most recent change of +$2.10 million (+38.39%) on 30 September 2024. Over the past year, it has increased by +$5.39 million (+61.57%). RNLX quarterly EBITDA is now -493.83% below its all-time high of -$567.00 thousand, reached on 30 June 2018.RNLX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$22.83 M
+$5.39 M+19.12%
30 September 2024
Summary:
Renalytix TTM earnings before interest, taxes, depreciation & amortization is currently -$22.83 million, with the most recent change of +$5.39 million (+19.12%) on 30 September 2024. Over the past year, it has increased by +$15.24 million (+40.03%). RNLX TTM EBITDA is now -3925.93% below its all-time high of -$567.00 thousand, reached on 30 June 2018.RNLX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNLX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.6% | +61.6% | +40.0% |
| 3 y3 years | +15.3% | +71.2% | +42.9% |
| 5 y5 years | +32.6% | -67.7% | -1036.8% |
RNLX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.9% | at high | +76.6% | at high | +56.7% |
| 5 y | 5 years | -178.4% | +45.9% | -67.7% | +76.6% | -1036.8% | +56.7% |
| alltime | all time | -178.4% | +45.9% | -493.8% | +76.6% | -3925.9% | +56.7% |
Renalytix EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.37 M(-38.4%) | -$22.83 M(-19.1%) |
| June 2024 | -$28.52 M(-31.6%) | -$5.46 M(-10.9%) | -$28.22 M(-13.4%) |
| Mar 2024 | - | -$6.14 M(-21.9%) | -$32.57 M(-12.8%) |
| Dec 2023 | - | -$7.86 M(-10.3%) | -$37.35 M(-1.9%) |
| Sept 2023 | - | -$8.76 M(-10.7%) | -$38.06 M(-6.9%) |
| June 2023 | -$41.71 M(-20.8%) | -$9.81 M(-10.1%) | -$40.89 M(-7.0%) |
| Mar 2023 | - | -$10.92 M(+27.4%) | -$43.99 M(-7.4%) |
| Dec 2022 | - | -$8.57 M(-26.1%) | -$47.49 M(-9.7%) |
| Sept 2022 | - | -$11.59 M(-10.2%) | -$52.59 M(-0.2%) |
| June 2022 | -$52.69 M | -$12.91 M(-10.4%) | -$52.69 M(+2.2%) |
| Mar 2022 | - | -$14.41 M(+5.4%) | -$51.56 M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$13.68 M(+16.9%) | -$45.15 M(+12.8%) |
| Sept 2021 | - | -$11.70 M(-0.8%) | -$40.01 M(+18.8%) |
| June 2021 | -$33.69 M(+228.8%) | -$11.78 M(+47.4%) | -$33.69 M(+36.1%) |
| Mar 2021 | - | -$7.99 M(-6.3%) | -$24.76 M(+27.4%) |
| Dec 2020 | - | -$8.54 M(+58.8%) | -$19.44 M(+42.8%) |
| Sept 2020 | - | -$5.38 M(+88.2%) | -$13.61 M(+32.9%) |
| June 2020 | -$10.24 M(-75.8%) | -$2.86 M(+6.9%) | -$10.24 M(+38.7%) |
| Mar 2020 | - | -$2.67 M(-1.4%) | -$7.39 M(+56.6%) |
| Dec 2019 | - | -$2.71 M(+35.0%) | -$4.72 M(+135.0%) |
| Sept 2019 | - | -$2.01 M(+254.1%) | -$2.01 M(+254.1%) |
| June 2019 | -$42.31 M | - | - |
| June 2018 | - | -$567.00 K | -$567.00 K |
FAQ
- What is Renalytix annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Renalytix?
- What is Renalytix annual EBITDA year-on-year change?
- What is Renalytix quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Renalytix?
- What is Renalytix quarterly EBITDA year-on-year change?
- What is Renalytix TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Renalytix?
- What is Renalytix TTM EBITDA year-on-year change?
What is Renalytix annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of RNLX is -$28.52 M
What is the all time high annual EBITDA for Renalytix?
Renalytix all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.24 M
What is Renalytix annual EBITDA year-on-year change?
Over the past year, RNLX annual earnings before interest, taxes, depreciation & amortization has changed by +$13.19 M (+31.63%)
What is Renalytix quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of RNLX is -$3.37 M
What is the all time high quarterly EBITDA for Renalytix?
Renalytix all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$567.00 K
What is Renalytix quarterly EBITDA year-on-year change?
Over the past year, RNLX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$5.39 M (+61.57%)
What is Renalytix TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of RNLX is -$22.83 M
What is the all time high TTM EBITDA for Renalytix?
Renalytix all-time high TTM earnings before interest, taxes, depreciation & amortization is -$567.00 K
What is Renalytix TTM EBITDA year-on-year change?
Over the past year, RNLX TTM earnings before interest, taxes, depreciation & amortization has changed by +$15.24 M (+40.03%)